STAT3 mediates an inflammation-induced microbial defense response and regulates pathogen control and clearance by macrophages
Open Access
- 11 November 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (2)
Abstract
STAT3 is pivotal for governing myeloid responses to inflammatory stimuli to prevent hyperinflammation in vivo, yet whether STAT3 mediates pathogen control and clearance by myeloid cells remains unclear. In this study, we identified significant enrichment of IFN-stimulated transcriptional pathways in Stat3-deficient bone marrow–derived macrophages (BMDMs) at steady state. This was accompanied by activation of autocrine type I IFN (IFN-I) and aberrant autocrine IL-6 signaling associated with increased STAT1 activity. Despite exaggerated baseline IFN-STAT1 signaling, Stat3-deficient BMDMs were significantly impaired in their ability to induce expression of key pathogen defense genes and specific immune mediators upon LPS stimulation. STAT3 was also required in Citrobacter rodentium–infected BMDMs for expression of pathogen defense genes and effective bacterial killing. Moreover, bone marrow chimeric mice with 20% Stat3-deficient hematopoietic cells were more susceptible to infection with C. rodentium and showed increased bacterial dissemination and reduced production of specific cytokines. IL-6 blockade subdued the intrinsic IFN response and rescued expression of select pathogen defense genes in Stat3-deficient BMDMs upon LPS stimulation yet was unable to restore bacterial killing activity. Taken together, our results identify novel functions for STAT3 in orchestrating an optimal microbial defense response and suggest this is regulated by discrete mechanisms including modulation of autocrine IL-6 signaling in macrophages.Keywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP170067)
- Cancer Prevention and Research Institute of Texas (RP210028)
- Cancer Prevention and Research Institute of Texas (RP210028)
- National Institutes of Health (R01AI133822)
- National Institutes of Health (R56AI109294-06)
- MD Anderson’s Advanced Cytometry and Sorting Facility
- National Cancer Institute (P30CA0166722)
This publication has 82 references indexed in Scilit:
- Interferonopathies: From concept to clinical practiceBest Practice & Research Clinical Rheumatology, 2024
- STAT3 regulates antiviral immunity by suppressing excessive interferon signalingCell Reports, 2023
- Type I interferon decreases macrophage energy metabolism during mycobacterial infectionCell Reports, 2021
- Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage DysfunctionCell Host & Microbe, 2017
- Bacterial Binding, Phagocytosis, and Killing: Measurements Using Colony Forming Units2016
- Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota AlterationsCell Host & Microbe, 2016
- Parsing the Interferon Transcriptional Network and Its Disease AssociationsCell, 2016
- The Ying and Yang of STAT3 in Human DiseaseJournal of Clinical Immunology, 2015
- Liver is the major source of elevated serum lipocalin‐2 levels after bacterial infection or partial hepatectomy: A critical role for IL‐6/STAT3Hepatology, 2014
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated TumorigenesisCancer Cell, 2009